Cover Image
市場調查報告書

全球核醫學市場預測

Global Nuclear Medicine Outlook 2020

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 346850
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
全球核醫學市場預測 Global Nuclear Medicine Outlook 2020
出版日期: 2015年12月07日 內容資訊: 英文 75 Pages
簡介

一般認為全球核醫學市場,今後數年將維持強有力的成長。市場預計2014年∼2020年以9.1%的年複合成長率成長。

本報告提供全球核醫學市場相關調查分析、市場現況與展望、主要趨勢、推動因素與阻礙因素、競爭情形與策略性分析等系統性資訊。

第1章 分析師的見解

第2章 調查手法

第3章 推動因素與課題

  • 推動因素
  • 課題

第4章 產業概要

  • 核醫學診斷市場
  • 核醫學治療市場
  • 核醫學市場:各地區

第5章 最近的趨勢與發展

  • 核醫學幫助:個體化醫療的成長
  • 從SPECT轉移到PET系統
  • 混合成像促進市場成長
  • 鉬-解除99不足的配合措施
  • 市場整合
  • 臨床試驗數的增加

第6章 競爭情形

  • Advanced Accelerator Applications
  • Mallinckrodt
  • Lantheus Medical Imaging
  • IBA
  • Cardinal Health Inc.
  • Nordion Inc.
  • Siemens Healthcare
  • GE Healthcare

圖表

目錄

Nuclear Medicine is one of the most promising segments of the medical imaging industry; and is becoming increasingly popular for disease diagnosis and treatment due to safe, painless and cost effective procedures. The Nuclear Medicine has been witnessing a steady demand over the past few years, backed by the worldwide increase in the number of cancer and cardiovascular cases, increasing awareness about early disease detection, and an ever increasing ageing population.

According to our research report, “Global Nuclear Medicine Outlook 2020”, the Global Nuclear Medicine market is anticipated to sustain a robust growth in the coming years also, growing at a CAGR of 9.1% during the forecasted period (2014 to 2020). The market growth is expected mainly due to the application of Nuclear Medicine in the treatment of diseases, with many players investing heavily in the research and development of new therapeutic agents. The report provides information on the current scenario, market segmentation on the basis of application and geography, and future forecasts on all prominent segments of the industry till 2020.

Our segment-level analysis showed that Nuclear Medicine Diagnostics currently holds the biggest share of the total Nuclear Medicine market. However, the segment is expected to witness a slow growth in the future due to competition from conventional technologies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), high cost of Nuclear Medicine equipments and shortage of major diagnostic radiopharmaceuticals. Considering the growth rates, the therapeutics segment is expected to grow at a faster rate by 2020 with an increase in use of radiopharmaceuticals for targeted therapy.

Our report has been authored to evaluate the Global Nuclear Medicine market potentials, and identify future growth opportunities. It provides extensive research and analysis on major factors propelling the growth of the industry, challenges holding back the industry, and latest trends and developments in the market.

The report also provides an insight into the market consolidation during 2014 & 2015. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information highlighting the opportunities in the Global Nuclear medicine market. The future analysis of the market scenario is likely to assist the intending clients to take informed and proactive business decisions in the evolving Nuclear Medicine market.

Table of Contents

1. Analyst View

2. Research Methodology

3. Drivers and Challenges

  • 3.1. Drivers
    • 3.1.1. Rising Incidences of Cancer and Cardiovascular Diseases
    • 3.1.2. Increasing Use of SPECT and PET Scans
    • 3.1.3. Rising Ageing Population
    • 3.1.4. Advances in Radiotracers
  • 3.2. Challenges
    • 3.2.1. Shut Down of Nuclear Reactors
    • 3.2.2. Short Half-life of Radiopharmaceuticals
    • 3.2.3. Production and Quality Control Challenges
    • 3.2.4. Reimbursement Issues

4. Industry Overview

  • 4.1. Nuclear Medicine Diagnostics Market
    • 4.1.1. Diagnostic Radiopharmaceuticals Market
    • 4.1.2. Nuclear Medicine Equipments Market
  • 4.2. Nuclear Medicine Therapeutics Market
  • 4.3. Nuclear Medicine Market by Geography

5. Recent Trends and Developments

  • 5.1. Nuclear Medicine: Aiding the Growth of Personalized Medicine
  • 5.2. Shift from SPECT to PET Systems
  • 5.3. Hybrid Imaging Propelling Market Growth
  • 5.4. Efforts Underway to Overcome Molybdenum-99 Shortage
  • 5.5. Consolidation in the Market
  • 5.6. Increasing Number of Clinical Trials

6. Competitive Landscape

  • 6.1. Advanced Accelerator Applications
  • 6.2. Mallinckrodt
  • 6.3. Lantheus Medical Imaging
  • 6.4. IBA
  • 6.5. Cardinal Health Inc.
  • 6.6. Nordion Inc.
  • 6.7. Siemens Healthcare
  • 6.8. GE Healthcare

List of Figures:

  • Figure 3-1: World - Number of Cancer Cases (Million), 2015 & 2035
  • Figure 3-2: World - Population Aged 60 and Above (Billion), 2014 & 2050
  • Figure 4-1: Global - Nuclear Medicine Market (Billion US$), 2014-2020
  • Figure 4-2: Nuclear Medicine Market Segmentation by Application (%), 2014
  • Figure 4-3: Nuclear Medicine Market Segmentation by Application (%), 2020
  • Figure 4-4: Nuclear Medicine Diagnostics Market Segmentation (%), 2014
  • Figure 4-5: Nuclear Medicine Diagnostics Market Segmentation (%), 2020
  • Figure 4-6: Global - Nuclear Medicine Diagnostics Market (Billion US$), 2014-2020
  • Figure 4-7: Medical Procedures Using Technetium - 99m (%), 2014
  • Figure 4-8: Global - Diagnostic Radiopharmaceuticals Market (Billion US$), 2014-2020
  • Figure 4-9: Global - Nuclear Medicine Equipments Market (Billion US$), 2014-2020
  • Figure 4-10: Global - Nuclear Medicine Therapeutics Market (Billion US$), 2014-2020
  • Figure 4-11: Global - Nuclear Medicine Market by Geographies (%), 2014

List of Tables:

  • Table 5-1: Recent M&A in the Global Nuclear Medicine Market (2014 - 2015)
  • Table 5-2: Major Products in the Pipeline
  • Table 6-1: Advanced Accelerator Applications - Revenue by Product Category (Million Euro), 2013 & 2014
  • Table 6-2: Advanced Accelerator Applications - Revenue by Countries (Million Euro), 2013 & 2014
  • Table 6-3: Advanced Accelerator Applications - Strengths & Weaknesses
  • Table 6-4: Mallinckrodt - Revenue by Business Segments (Million US$), 2013 & 2014
  • Table 6-5: Mallinckrodt - Revenue Breakup for Global Medical Imaging Segment (Million US$), 2013 & 2014
  • Table 6-6: Mallinckrodt - Strengths & Weaknesses
  • Table 6-7: Lantheus Medical Imaging - Revenue by Products (Million US$), 2013 & 2014
  • Table 6-8: Lantheus Medical Imaging - Strengths & Weaknesses
  • Table 6-9: IBA - Revenue by Business Segments (Million Euro), 2013 & 2014
  • Table 6-10: IBA - Strengths & Weaknesses
  • Table 6-11: Cardinal Health Inc. - Revenue by Business Segments (Billion US$), 2013 & 2014
  • Table 6-12: Cardinal Health Inc. - Strengths & Weaknesses
  • Table 6-13: Nordion Inc. - Strengths & Weaknesses
  • Table 6-14: Siemens Healthcare - Strengths and Weaknesses
  • Table 6-15: GE Healthcare - Strengths and Weaknesses
Back to Top